How Much Weight Loss on Mounjaro? (October 2026)

01 · The core answer

The honest answer on Mounjaro weight loss

The most reliable figures come from the SURMOUNT-1 trial, and they are averages over a long period. The trial lasted 72 weeks, so those results describe what happened across more than a year of treatment alongside diet and exercise, not what happens in a month. Any page that promises a precise number for a short window is guessing, because trial results are averages over 72 weeks.

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

Averages hide a wide spread. Some people in the trial lost far more than the average, and some lost less. If you want a realistic picture of your own likely range, our guides on Mounjaro expected weight loss and Mounjaro predicted weight loss go through how to think about it without false precision.

02 · Is this relevant to me?

What this means for your own expectations

Treat the trial figures as a guide to direction and scale, not a target you must hit.

A sensible way to judge progress is over months, with your prescriber, rather than by weekly weigh-ins. Scale weight moves up and down for reasons unrelated to the medicine.

03 · What to do next

What to do next

If you are still deciding whether treatment is right for you, start with a free consultation, reviewed by a GPhC-registered prescriber, who will check suitability and explain the dose plan. You can see current options on our weight loss clinic page. For a wider breakdown, see how much Mounjaro costs in the UK.

Mounjaro (tirzepatide) is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.

04 · Trial results explained

Trial results explained: what SURMOUNT-1 found

SURMOUNT-1 is the main trial behind the weight-management licence for tirzepatide, and it is the source of most figures you will see quoted online. It followed adults over 72 weeks and compared different doses of tirzepatide with a comparison group who made lifestyle changes alone. Everyone in the trial was supported with diet and activity advice, which matters when you interpret the numbers.

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² The gap between the medicine groups and the lifestyle-only group is the useful part. It shows that diet and activity on their own produced a much smaller average change over the same period.

These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² An average is the middle of a spread. Some participants lost more, some less, and the average does not predict what any single person will experience.

The trial also reported how many people reached particular thresholds. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.² Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² Those figures show that the large majority of people on treatment lost a meaningful amount, while a smaller group reached very large losses.

It is worth being careful about what you do with these numbers. They come from a controlled research setting with regular monitoring and structured support. Real-world experience is shaped by tolerability, how long someone stays on a dose, and everyday circumstances.

If you would like to understand the upper end of what some people achieve, our page on the biggest weight loss on Mounjaro looks at outliers and why they should not set your expectations. The sensible reading of SURMOUNT-1 is that treatment, combined with lifestyle change and time, produced substantial average loss across all doses studied, with higher doses producing larger averages.

05 · How it works

How Mounjaro works and why that shapes results

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in strengths of 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹

That last point is the key to understanding results. The medicine does not burn fat directly. It changes appetite and fullness, which makes it easier to eat less. Weight loss follows from sustained changes in what you eat, supported by increased physical activity. If appetite reduction is strong but you eat poorly, or if you do not adjust your habits, the benefit will be smaller than the trial averages suggest.

This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy and Ozempic).¹

The slow-stomach-emptying effect also explains why dose increases are gradual. Your body adapts to the medicine over time, and stepping up under prescriber review helps you stay comfortable while the effect builds. That is why the earliest weeks are rarely the most dramatic. If you want to read about the appetite side specifically, see our guide to loss of appetite on Mounjaro.

Because the effect depends on appetite, anything that interferes with regular dosing can interrupt it. Keeping to the once-weekly schedule your prescriber sets is the simplest way to give the treatment a fair chance to work, and your monthly reviews are a good time to talk through how appetite and fullness are changing for you.

06 · The first weeks

What to expect in the first weeks and the first month

In the first weeks, expect a gentle start rather than dramatic change. Treatment begins at the lowest strength, 2.5mg, and the dose is stepped up gradually under prescriber review.¹ The purpose of the starter dose is to let your body adjust. It is not designed to deliver the largest effect.

This is where many online pages mislead. You will see neat week-by-week tables with precise percentages for the first month, the third month and so on. When someone asks how much weight they can lose in four weeks, the honest answer is that it varies widely, and some people notice appetite changes quickly while others take longer.

What you can reasonably notice early is a change in how hungry you feel and how quickly you feel full. For many people this appears within the first few weeks. Whether that translates into a visible change on the scales depends on what you eat, how much you move, and natural fluctuations in water and digestion.

Some practical points help you judge early progress sensibly:

• Weigh yourself at the same time of day, under similar conditions, and look at the trend over several weeks rather than day to day.
• Notice non-scale changes such as portion sizes, cravings, and how clothes fit.
• Tell your prescriber if you feel unwell, cannot eat enough, or are unsure about anything in the patient information leaflet.¹³

Do not rush to a higher dose because early loss feels slow. Dose changes are a clinical decision made at your review, and moving up faster than advised is not appropriate. Each step is there for tolerability as well as effect.

Many people find tracking helps them stay realistic. Our free companion app, GLPTrackr, lets you log doses and progress on iOS or Android.

Remember that the first month is the start of a long process. The trial results that headline Mounjaro came from 72 weeks of treatment, and patience in the early stage is part of the plan rather than a sign that it is not working.

07 · What shapes your result

What shapes your own result

Your result depends on a handful of factors that no average can capture. Understanding them helps you set expectations that are fair to yourself and keeps you from comparing your progress with a stranger's.

The first factor is dose. In SURMOUNT-1, higher maintenance doses were associated with larger average losses, rising from 5mg to 10mg to 15mg.² But a higher dose is not automatically better for you. The right dose is the one you tolerate, that your prescriber judges appropriate, and that you can keep taking consistently.

The second is time. The trial figures reflect 72 weeks of treatment. Someone a few months in has simply not had the same exposure, so comparing their loss with a 72-week average is not like for like.

The third is lifestyle. The medicine is used alongside a reduced-calorie diet and increased physical activity.² In the trial, the comparison group using lifestyle changes alone lost far less on average than the treatment groups, but the treatment groups were also following lifestyle advice. The two work together. Protein-aware meals, regular movement and good sleep all make the treatment easier to live with.

The fourth is tolerability. If side effects lead to missed doses, very low food intake or stopping altogether, your outcome changes. Raise problems early at your monthly review. Support from the prescribing team is part of ongoing care, and adjusting the plan is better than struggling silently.

The fifth is your starting point and your body. People differ in age, metabolism, medical conditions, other medicines and sleep.

Finally, consider what you measure. Percentage of body weight is how trials report results, and it is a fairer yardstick than raw pounds or kilograms because it scales with starting weight. Health markers, energy, mobility and how you feel are also meaningful measures, and you should discuss them with your prescriber alongside the scales.

If your progress looks slower than you expected, that is a reason to review dose, diet, activity and side effects with your prescriber, not a reason to change the medicine yourself.

08 · Safety and side effects

Safety and side effects of weight loss injections

Like all medicines, Mounjaro can cause side effects, and the full list belongs in the patient information leaflet that comes with every pen.¹³

Read the leaflet before your first dose. Keep a note of any new symptom, when it started and how it relates to your injection day and meals. Tell your prescriber at your monthly review, or sooner if something concerns you. Do not adjust your dose, skip doses or stop treatment on your own without speaking to the prescribing team first.

Because the medicine slows how quickly the stomach empties, it can affect how other things are absorbed.¹ Tell your prescriber about every medicine you take. Tell them too if you use oral contraceptives, as the medicine can reduce absorption of oral contraceptives because stomach emptying slows. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ Your prescriber can explain what that means for you. If you take insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar, so make sure the prescriber knows.

Discuss any new symptom with your prescriber, and report suspected side effects through the MHRA Yellow Card scheme.¹⁹ Reports help regulators monitor safety across the UK.

Be wary of anyone offering to supply weight loss injections without a consultation or prescription. Counterfeit medicines are a real hazard, and an unregulated product can be unsafe whatever it claims to contain. Genuine Mounjaro is supplied by registered pharmacies. Ours is registered with the GPhC under number 9012878, and supply comes from official LillyDirect distribution.

Finally, remember that safety includes feeling able to eat and drink adequately. If you are struggling with that, or you cannot keep fluids down, contact your clinical team — dehydration needs medical help straight away.

09 · Stopping Mounjaro

When to stop Mounjaro and what happens afterwards

The decision about when to stop belongs in a conversation with your prescriber, not in a rush. Reasons people stop include reaching a goal, side effects, a change in circumstances, or cost. Each has a different sensible route, and a review is the right place to talk it through.

It helps to know what happens to the medicine in your body. Tirzepatide has a long half-life, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ That means stopping is not a sudden switch. The effect fades gradually as the level in your body falls.

Before you stop, tell your prescriber. They can talk through what to expect, whether to continue at a lower dose, and how to keep your diet and activity habits going.

Appetite is the thing most people notice returning. As the medicine clears, the fullness it provided fades, and hunger comes back. Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load. Planning for that is far better than being surprised by it. Keep the eating and activity habits you built, ask your prescriber about a plan, and keep in touch about how you feel.

Mounjaro is once-weekly, and any alteration to the schedule should come from your prescriber. We offer a free consultation, reviewed by a GPhC-registered prescriber, repeat orders re-check suitability, and there is no auto-shipping or subscription, so you stay in control of when you order.

Whatever you decide, stopping does not mean you failed. It is a decision to make with support, and the habits you formed stay useful.

10 · NHS and private

NHS and private routes to treatment

Mounjaro is available on the NHS, but access is being phased in over several years.⁵ NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you think you may qualify on the NHS, the first step is to speak to your GP. They will know how the rollout is working locally and can tell you whether you fall into a current group. Nothing about choosing private care closes that door, but the two routes involve different timelines.

For private treatment, the route is straightforward and we describe it as it works. First, you complete a free online consultation, which is a short health questionnaire with no charge and no obligation. Second, the answers are reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Third, the medicine is dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm. Delivery is free next-day tracked, in temperature-controlled, discreet packaging, with Saturday delivery available for £14.99.

Costs matter, and we keep them transparent. The consultation is free, and the price shown is the price paid, with no hidden fees. You can pay by Visa, Mastercard or Klarna, with pay-monthly options and no subscriptions. The Mounjaro pen page shows all doses, and for planning over time see our guide to Mounjaro prices in the UK.

Private care also includes ongoing monthly reviews, dose titration and follow-up assessments by the prescribing team, with side-effect support. We supply genuine KwikPens through official LillyDirect supply. Support is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, account portal chat, or phone on 0333 207 0413.

Choose whichever route fits your situation. The medicine and the evidence behind it are the same, and the aim is to start safely with a prescriber who reviews your progress.

11 · Setting goals

Setting realistic goals and tracking progress

Good goals are specific to you, flexible, and reviewed with your prescriber. The trial averages tell you what is possible across a large group over a long time. They do not tell you what you should expect next month, and treating them as a deadline is a recipe for disappointment.

Start by deciding what you actually want. Many people say a number on the scales, but often the real aim is health, mobility, energy, blood sugar or confidence. Naming that aim helps you recognise progress even when the scales hold still for a while. It also gives you something to discuss at your monthly review.

Next, choose how you will measure. Percentage change in body weight is how trials report results, and it is fairer than raw figures because it scales with where you started. Keep a simple record over time. Our free GLPTrackr app can log doses and measurements on iOS or Android, and a notebook works too. Look at trends across several weeks, not single readings.

Then think about habits. The medicine is used alongside a reduced-calorie diet and increased physical activity.² Reasonable steps include building regular meals that suit smaller appetites, choosing foods that keep you satisfied, moving in ways you enjoy, and protecting sleep.

Expect plateaus and uneven weeks. Weight is affected by hydration, digestion, hormones and routine. A pause does not mean the medicine has stopped working. If a plateau lasts and you are worried, raise it at your review so the prescriber can look at dose, intake, activity and tolerability together.

Finally, plan beyond the loss itself. Think about what maintenance looks like, how you will keep the habits, and what you will do if you decide to stop. Talking about those questions early makes the whole journey calmer and more sustainable.

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹